Progyny, Inc. (PGNY) News
Follow Progyny, Inc. (PGNY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
PGNY: Stable demand, expanding products, and strong cost control support robust growth outlook
Seasonal utilization softness was noted but is seen as normal, with stable demand expected for the year. Growth is driven by expanding market acceptance, new risk-based products for smaller employers, and ongoing cost co
EQUITY | Sep 08, 2026, 04:49 PM UTC
L
PGNY cites stable demand and new offerings amid cost pressures
PGNY says seasonal utilization softness is expected to be normal, while stable demand should hold for the year. Growth drivers include smaller employers, global markets and new products; capital goes to innovation, M&A a
MNA | Sep 08, 2026, 04:20 PM UTC
L
Citizens raises Progyny price target to $33 from $31
Citizens, via Benzinga, maintained Progyny’s Market Outperform rating and raised its price target to $33.00 per share from $31.00.
EQUITY | Sep 08, 2026, 01:46 PM UTC
L
Progyny to present at Wells Fargo Healthcare Conference
Progyny, Inc. said it will present at the Wells Fargo Healthcare Conference.
EQUITY | Sep 03, 2026, 03:16 PM UTC
L
Wells Fargo initiates PGNY at Overweight, $37.00 price target
Wells Fargo initiates PGNY with an Overweight rating and a $37.00 price target, according to the report.
EQUITY | Aug 20, 2026, 11:56 AM UTC
L
Progyny Raises FY2026 Adj EPS Guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 Est; Lowers FY2026 Sales Guidance from $1.365B-$1.405B to $1
Progyny (NASDAQ: PGNY ) raises FY2026 Adj EPS guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 analyst estimate. Lowers FY2026 sales outlook from $1.365 billion-$1.405 billion to $1.360 billion-$1.385 billion vs $1.384
EARNINGS | Aug 06, 2026, 08:02 PM UTC
L
PGNY downgraded to EW from OW, but raise PT to $34 from $27 @ BARC
PGNY downgraded to EW from OW, but raise PT to $34 from $27 @ BARC
EQUITY | Jul 28, 2026, 11:41 AM UTC
L
Top Downgrades: ACI: NEUTRAL @ UBS CAPR: NEUTRAL @ ROTH CAT: HOLD @ Erste CLX: HOLD @ Jefferies EBC: EQUAL WEIGHT @ Stephens INTU: HOLD @ TD
Top Downgrades: ACI: NEUTRAL @ UBS CAPR: NEUTRAL @ ROTH CAT: HOLD @ Erste CLX: HOLD @ Jefferies EBC: EQUAL WEIGHT @ Stephens INTU: HOLD @ TD Cowen LAUR: UNDERWEIGHT @ MS LEVI: EQUAL WEIGHT @ WFC MPLT: EQUAL WEIGHT @ MS P
EQUITY | Jul 28, 2026, 11:11 AM UTC